426 related articles for article (PubMed ID: 9054223)
1. Therapeutic uses of botulinum toxin.
Wheeler AH
Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in movement disorders.
Papapetropoulos S; Singer C
Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
[TBL] [Abstract][Full Text] [Related]
3. [Clinical symptoms, diagnosis and treatment of focal dystonias].
Klivényi P; Vécsei L
Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645
[TBL] [Abstract][Full Text] [Related]
4. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm].
Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M
No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919
[TBL] [Abstract][Full Text] [Related]
5. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
Kraft SP; Lang AE
CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
[TBL] [Abstract][Full Text] [Related]
6. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
Calne S
Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Kenney C; Jankovic J
J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
[TBL] [Abstract][Full Text] [Related]
8. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
9. [Hemifacial spasms. Causes, clinical findings and treatment].
Ringstad O; Kerty E
Tidsskr Nor Laegeforen; 1995 Sep; 115(22):2777-9. PubMed ID: 7570493
[TBL] [Abstract][Full Text] [Related]
10. [Blepharospasm: treatment with botulinum toxin].
Barbosa ER; Silva HC; Haddad MS; Bittar MS
Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin: clinical use.
Truong DD; Jost WH
Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin therapy.
Savino PJ; Maus M
Neurol Clin; 1991 Feb; 9(1):205-24. PubMed ID: 2011110
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
Stefanoff P; Kiliszek M; Friedman A
Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin. Development for therapeutic purposes].
Ceballos-Baumann A
Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin: a dreaded toxin for use in human being.
Ghosh B; Das SK
J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
Whitaker J; Butler A; Semlyen JK; Barnes MP
Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin as a therapeutic agent.
Tsui JK
Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
19. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
[TBL] [Abstract][Full Text] [Related]
20. Restoring balance in focal limb dystonia with botulinum toxin.
Sheean G
Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
